Percutaneous transluminal coronary angioplasty, PTCA in Israel

Percutaneous coronary intervention can be performed to reduce or eliminate the symptoms of coronary artery disease, including angina (chest pain), dyspnea (shortness of breath) on exertion, and congestive heart failure. PCI is also used to abort an acute miocardial infarction, and in some specific cases it may reduce death .Angioplasty is less invasive than coronary artery bypass surgery (CABG). However, CABG has better results in terms of death, myocardial infarction, and the need to repeat the procedure. This was demonstrated in repeated studies. A 2002 randomized controlled trial found that bare metal stents had no benefit over CABG.


 


A 2008 randomized controlled trial found that drug-coated stents did not reduce death in non-acute cases. The COURAGE trial concluded that treating with PCI for stable coronary artery disease did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to standard medical treatment.. A 2008 retrospective study found a lower death rate for CABG. PCI did have a small effect on improving quality of life.